SEC 13F Intelligence

Highvista Strategies LLC / ISI

Highvista Strategies LLC’s Ionis Pharmaceuticals Inc Position

Does Highvista Strategies LLC own Ionis Pharmaceuticals Inc (ISI)? Not currently — the last reported position was 57.3K shares worth $3M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q4 2023
Shares
57.3K
% of Portfolio
+1.05%
Quarters Held
2
position exited

Position History ISI

Reported value by quarter
Q3 ’23: $2MQ3 ’23Q4 ’23: $3MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202357.3K$3M+1.05%
Q3 202348.5K$2M+1.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of ISI.